Shyng S L, Ferrigni T, Shepard J B, Nestorowicz A, Glaser B, Permutt M A, Nichols C G
Department of Cell Biology and Physiology, Washington University School of Medicine, St. Louis, Missouri 63110, USA.
Diabetes. 1998 Jul;47(7):1145-51. doi: 10.2337/diabetes.47.7.1145.
The ATP-sensitive potassium channel, K(ATP) channel, a functional complex of the sulfonylurea receptor 1, SUR1, and an inward rectifier potassium channel subunit, Kir6.2, regulates insulin secretion in the pancreas. Mutations in both the Kir6.2 and SUR1 genes are associated with persistent hyperinsulinemic hypoglycemia of infancy (PHHI), a disorder of pancreatic beta-cell function characterized by excess insulin secretion and hypoglycemia. We have studied the functional properties of novel SUR1 mutations identified in PHHI patients, including H125Q, N188S, F591L, T1139M, R1215Q, G1382S, and R1394H. R1394H and deltaF1388 SUR1, a previously identified PHHI mutation, resulted in no functional channels when coexpressed with Kir6.2 in COS cells, while H125Q, N188S, F591L, T1139M, R1215Q, and G1382S SUR1 generated functional channels in the absence of ATP. With the exception of N188S and H125Q, all mutants had reduced response to stimulation by MgADP. These results indicate that lack of, or reduction of, K(ATP) channel sensitivity to MgADP is a common molecular defect associated with the disease. The mutant channels also showed varied response to activation by the potassium channel opener diazoxide. Because these mutations are distributed throughout the molecule, our data have new implications for structure-function relationships of the K(ATP) channel, suggesting that structural elements in SUR1 outside of the two nucleotide-binding folds are also important in regulating channel activity.
ATP敏感性钾通道(K(ATP)通道)是磺脲类受体1(SUR1)与内向整流钾通道亚基Kir6.2形成的功能复合体,可调节胰腺中的胰岛素分泌。Kir6.2和SUR1基因的突变均与婴儿持续性高胰岛素血症性低血糖症(PHHI)相关,PHHI是一种胰腺β细胞功能障碍疾病,其特征为胰岛素分泌过多和低血糖。我们研究了在PHHI患者中鉴定出的新型SUR1突变的功能特性,包括H125Q、N188S、F591L、T1139M、R1215Q、G1382S和R1394H。R1394H和δF1388 SUR1(一种先前鉴定出的PHHI突变)与Kir6.2在COS细胞中共表达时未产生功能性通道,而H125Q、N188S、F591L、T1139M、R1215Q和G1382S SUR1在无ATP的情况下产生了功能性通道。除N188S和H125Q外,所有突变体对MgADP刺激的反应均降低。这些结果表明,K(ATP)通道对MgADP的敏感性缺乏或降低是与该疾病相关的常见分子缺陷。突变通道对钾通道开放剂二氮嗪激活的反应也各不相同。由于这些突变分布于整个分子,我们的数据对K(ATP)通道的结构-功能关系有新的启示,表明SUR1中两个核苷酸结合结构域之外的结构元件在调节通道活性方面也很重要。